Lataa...
Epigenetic drug combination induces remission in mouse xenograft models of pediatric acute myeloid leukemia
Aberrations in epigenetic modifications contribute to leukemogenesis in childhood acute myeloid leukemia (AML). We combined DNA hypomethylating agent azacitidine with histone deacetylase inhibitor panobinostat in preclinical models of childhood AML. Synergistic cytotoxic effect upon treatment with a...
Tallennettuna:
| Julkaisussa: | Leuk Res |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5507334/ https://ncbi.nlm.nih.gov/pubmed/28505595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2017.05.004 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|